All In Biotech

Free tool

FAERS Monitor: Marcaine Hydrochloride W/ Epinephrine Preservative Free

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 016964 or its brand name (Marcaine Hydrochloride W/ Epinephrine Preservative Free, Bupivacaine Hydrochloride, Epinephrine Bitartrate). Reports on generic versions are filed under their own applications.

Reports

4,747

Serious

2,732

58% of reports

Hospitalization

1,140

Death reported

318

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,603
  • anaesthetic complication278
  • off label use246
  • pain228
  • hypoaesthesia213
  • maternal exposure during pregnancy211
  • hypotension199
  • headache181
  • dyspnoea169
  • dizziness154
  • nausea149
  • condition aggravated144
  • fatigue144
  • hypertension143
  • vomiting137

Reports by year received

View as table
YearReports
200492
200577
200697
200765
200885
2009124
2010104
2011101
201294
201394
2014112
2015191
2016619
2017390
2018241
2019242
2020242
2021200
2022407
2023256
2024331
2025336
2026247

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,412 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
anaesthetic complicationSignal278511.5453.3126,552
maternal exposure during pregnancySignal21110.59.21,810
hypoaesthesiaSignal2136.35.5952
drug ineffectiveSignal1,6035.45.26,110
hypotensionSignal1994.43.8524
hypertensionSignal1433.02.5190
condition aggravatedSignal1442.11.883
pain2281.61.459
dizziness1541.41.215
dyspnoea1691.31.113
vomiting1371.31.19
headache1811.31.111
off label use2461.21.112
nausea1490.80.75
fatigue1440.80.76

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.